{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:19:18Z","timestamp":1787242758434,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jocn-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jocn.2024.110956","type":"journal-article","created":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T20:11:17Z","timestamp":1733429477000},"page":"110956","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Benefits and risks of antiplatelet therapy after bypass surgery for moyamoya disease: A meta-analysis"],"prefix":"10.1016","volume":"132","author":[{"given":"Junchen","family":"Si","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokui","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiheng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2024.110956_b0005","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2024.110956_b0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2176\/nmc.52.295","article-title":"Epidemiological features of moyamoya disease in Japan","volume":"52","author":"Hoshino","year":"2012","journal-title":"Neurol Med Chir"},{"issue":"4","key":"10.1016\/j.jocn.2024.110956_b0015","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1136\/svn-2020-000770","article-title":"Effects and safety of aspirin use in patients after cerebrovascular bypass procedures","volume":"6","author":"Lu","year":"2021","journal-title":"Stroke Vasc Neurol"},{"key":"10.1016\/j.jocn.2024.110956_b0020","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.wneu.2017.06.057","article-title":"Effect of aspirin in postoperative management of adult ischemic moyamoya disease","volume":"105","author":"Zhao","year":"2017","journal-title":"World Neurosurg"},{"issue":"1","key":"10.1016\/j.jocn.2024.110956_b0025","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-1331.2011.03481.x","article-title":"What is the expert's option on antiplatelet therapy in moyamoya disease? Results of a worldwide Survey","volume":"19","author":"Kraemer","year":"2012","journal-title":"Eur J Neurol"},{"issue":"339","key":"10.1016\/j.jocn.2024.110956_b0030","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"21","author":"Liberati","year":"2009","journal-title":"BMJ"},{"issue":"11","key":"10.1016\/j.jocn.2024.110956_b0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3389\/fneur.2020.00517","article-title":"Hemorrhagic transformation in ischemic moyamoya disease: clinical characteristics, radiological features, and outcomes","volume":"25","author":"Lu","year":"2020","journal-title":"Front Neurol"},{"issue":"11","key":"10.1016\/j.jocn.2024.110956_b0040","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S1474-4422(08)70240-0","article-title":"Moyamoya disease: current concepts and future perspectives","volume":"7","author":"Kuroda","year":"2008","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2024.110956_b0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.nec.2017.02.004","article-title":"Direct versus indirect bypass for moyamoya disease","volume":"28","author":"Liu","year":"2017","journal-title":"Neurosurg Clin N Am"},{"issue":"13","key":"10.1016\/j.jocn.2024.110956_b0050","article-title":"Effects of aspirin therapy on bypass efficacy and survival of patients receiving direct cerebral revascularization","volume":"3","author":"Xiang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.jocn.2024.110956_b0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s10143-019-01086-4","article-title":"Predictive factors for acute thrombogenesis occurring immediately after bypass procedure for moyamoya disease","volume":"43","author":"Mikami","year":"2020","journal-title":"Neurosurg Rev"},{"issue":"5","key":"10.1016\/j.jocn.2024.110956_b0060","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s00701-020-04668-0","article-title":"Effects of aspirin and heparin treatment on perioperative outcomes in patients with Moyamoya disease","volume":"163","author":"Kanamori","year":"2021","journal-title":"Acta Neurochir (Wien)"},{"issue":"10","key":"10.1016\/j.jocn.2024.110956_b0065","article-title":"Safety and efficacy of aspirin after combined cerebral revascularization for ischemic moyamoya disease: A prospective study","volume":"24","author":"Xue","year":"2023","journal-title":"Front Surg"},{"issue":"12","key":"10.1016\/j.jocn.2024.110956_b0070","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.08.030","article-title":"Research committee on spontaneous occlusion of circle of willis (Moyamoya disease). trends of antiplatelet therapy for the management of moyamoya disease in japan: results of a nationwide survey","volume":"27","author":"Oki","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"5","key":"10.1016\/j.jocn.2024.110956_b0075","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.wneu.2013.06.010","article-title":"Risk profile in extracranial\/intracranial bypass surgery\u2013the role of antiplatelet agents, disease pathology, and surgical technique in 168 direct revascularization procedures","volume":"82","author":"Schubert","year":"2014","journal-title":"World Neurosurg"},{"issue":"14","key":"10.1016\/j.jocn.2024.110956_b0080","article-title":"Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis","volume":"20","author":"Liu","year":"2023","journal-title":"Front Neurol"},{"issue":"5","key":"10.1016\/j.jocn.2024.110956_b0085","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1227\/NEU.0b013e31820c045a","article-title":"Epilepsy after bypass surgery in adult moyamoya disease","volume":"68","author":"Jin","year":"2011","journal-title":"Neurosurgery"},{"key":"10.1016\/j.jocn.2024.110956_b0090","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/j.wneu.2023.11.075","article-title":"Predictive factors for seizures after revascularization in patients with moyamoya disease","volume":"182","author":"Huang","year":"2024","journal-title":"World Neurosurg"},{"key":"10.1016\/j.jocn.2024.110956_b0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-7091-0661-7_6","article-title":"Genetic and clinical characteristics of moyamoya disease in europeans","volume":"112","author":"Krischek","year":"2011","journal-title":"Acta Neurochir Suppl"},{"issue":"8","key":"10.1016\/j.jocn.2024.110956_b0100","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00415-020-09837-w","article-title":"Moyamoya angiopathy: radiological follow-up findings in finnish patients","volume":"267","author":"Savolainen","year":"2020","journal-title":"J Neurol"},{"issue":"6","key":"10.1016\/j.jocn.2024.110956_b0105","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00415-019-09277-1","article-title":"Clinical presentation of Moyamoya angiopathy in Europeans: experiences from Germany with 200 patients","volume":"266","author":"Kraemer","year":"2019","journal-title":"J Neurol"},{"issue":"9303","key":"10.1016\/j.jocn.2024.110956_b0110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(02)07500-1","article-title":"Cohort studies: marching towards outcomes","volume":"359","author":"Grimes","year":"2002","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jocn.2024.110956_b0115","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.10.003","article-title":"Research committee on spontaneous occlusion of circle of willis (Moyamoya Disease). effects of surgery and antiplatelet therapy in ten-year follow-up from the registry study of research committee on moyamoya disease in japan","volume":"25","author":"Yamada","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10","key":"10.1016\/j.jocn.2024.110956_b0120","article-title":"Moyamoya: an update and review","volume":"12","author":"Berry","year":"2020","journal-title":"Cureus"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824004958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824004958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T15:10:42Z","timestamp":1737731442000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586824004958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":24,"alternative-id":["S0967586824004958"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110956","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Benefits and risks of antiplatelet therapy after bypass surgery for moyamoya disease: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2024.110956","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110956"}}